SCHEMBL9013639

SCHEMBL9013639

NCCSC1c2ccccc2C=Cc2ccccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 4/20 0.52
TBXA2R P21731 1/20 0.40
CYP2D6 P10635 5/20 0.35
CYP3A4 P08684 3/20 0.35
KDM4E B2RXH2 2/20 0.35
SLC6A3 Q01959 2/20 0.35
HRH1 P35367 2/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
DRD2 P14416 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
NFKB1 P19838 1/20 0.35
CHRM3 P20309 1/20 0.35
SLC6A2 P23975 1/20 0.35
HTR2C P28335 1/20 0.35
ADRA1A P35348 1/20 0.35
DRD3 P35462 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9016803 0.70 TBXA2R (0.44) HTR2ATBXA2RKDM4ELMNACYP1A2
SCHEMBL8256345 0.69 HTR2A (0.69) HTR2ACYP2D6CYP3A4KDM4ESLC6A3
SCHEMBL9372217 0.69 TBXA2R (0.46) HTR2ATBXA2RHRH1HTR2C
SCHEMBL11335219 0.69 HTR2A (1.00) HTR2ACYP2D6CYP3A4KDM4ESLC6A3
SCHEMBL14459215 0.68 KIF11 (0.47) TBXA2RKIF11
SCHEMBL11726371 0.67 HTR2A (0.64) HTR2ACYP2D6CYP3A4KDM4ESLC6A3
SCHEMBL20787747 0.65 HTR2A (0.52) HTR2ACYP2D6CYP3A4KDM4ESLC6A3
SCHEMBL10080430 0.65 HTR2A (0.56) HTR2ACYP2D6CYP3A4KDM4ESLC6A3
Hydrochloric Acid SCHEMBL9691406 0.63 HTR2A (0.54) HTR2ACYP2D6CYP3A4KDM4ESLC6A3
SCHEMBL5677282 0.63 HTR2A (0.48) HTR2ACYP2D6CYP3A4KDM4ESLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0740649-A1 NITROXY GROUP-CONTAINING BENZYLAMINE DERIVATIVES AND THEIR USE FOR TREATING CARDIOVASCULAR DISEASES, AS WELL AS INCREASED INTRA-OCULAR PRESSURE Byk Nederland BV (NL) 1996-11-06 EP disclosed
WO-1995019952-A1 NITROXY GROUP-CONTAINING BENZYLAMINE DERIVATIVES AND THEIR USE FOR TREATING CARDIOVASCULAR DISEASES, AS WELL AS INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1995-07-27 WO disclosed